Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Annual Revenue ($)
Zymeworks revenue was $26.68 m in FY, 2021
Quarterly Revenue ($)
| FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | |
|---|---|---|---|---|
| Revenue | $53.02 m | $29.54 m | $38.95 m | $26.68 m |
| Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.93 m | $7.88 m | $7.86 m | $8.27 m | $12.36 m | $2.64 m | $644 k | $1.77 m | $4.4 m | $1.92 m |
Revenue Breakdown
Business Segment
Geographic Segment
Zymeworks revenue breakdown by business segment: 100.0% from CLINICAL-STAGE BIOPHARMACEUTICAL
Zymeworks revenue breakdown by geographic segment: 100.0% from CANADA
| FY, 2021 | FY, 2020 | FY, 2018 | FY, 2019 | |
|---|---|---|---|---|
| CLINICAL-STAGE BIOPHARMACEUTICAL | $26.68 k | $38.95 k | $53.02 k | $29.54 k |
| FY, 2021 | FY, 2020 | FY, 2018 | FY, 2019 | |
|---|---|---|---|---|
| CANADA | $26.68 k | $38.95 k | $53.02 k | $29.54 k |
Need Data?
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.